pre-seed
Stage
About
Passkey Therapeutics develops a computational genetics-based platform called Locksmith® that identifies synergistic combinations of approved and late-stage drugs to treat complex diseases by bypassing traditional preclinical development and proceeding directly to clinical testing.
Explore Passkey Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.